BioCorteX Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer. (NCT06126003) | BioCorteX Inc | 2023-12-01 |
Track BioCorteX Inc automatically
Every clearance here is in the API, with alerts when new ones post.